期刊信息查詢系統

期刊標題檢索 CURR VASC PHARM 最新評論: It has been three months awaiting editorial approval (2024-04-10)

讓學術交流變得簡單

發布您的作品並從國際研究社群獲取反饋

APA 與 LetPub 合作，為作者提供全方位服務

[Current Vascular Pharmacology]您好，您是該頁面的第 16496 位訪客。

期刊簡介

期刊名稱

Current Vascular Pharmacology
LetPub Score

5.2

50 ratings

Rate

Reputation

6.4

Influence

3.9

Speed

7.0

期刊簡稱

CURR VASC PHARMACOL

ISSN

1570-1611

E-ISSN

1875-6212

h-index

CiteScore

SJR

SNIP

CiteScore Rank

9.20

0.991

1.289

Subject field	Quartiles	Rank	Percentile
Category: Pharmacology, Toxicology and Pharmaceutics Subcategory: Pharmacology	Q1	42 / 313
Category: Pharmacology, Toxicology and Pharmaceutics Subcategory: Cardiology and Cardiovascular Medicine	Q1	52 / 387

自引率 (2023-2024)

3.60%自引率趨勢

掲載範囲

Current Vascular Pharmacology publishes clinical and research-based reviews/mini-reviews, original research articles, letters, debates, drug clinical trial studies and guest edited issues to update all those concerned with the treatment of vascular disease, bridging the gap between clinical practice and ongoing research.

Vascular disease is the commonest cause of death in Westernized countries and its incidence is on the increase in developing countries. It follows that considerable research is directed at establishing effective treatment for acute vascular events. Long-term treatment has also received considerable attention (e.g. for symptomatic relief). Furthermore, effective prevention, whether primary or secondary, is backed by the findings of several landmark trials. Vascular disease is a complex field with primary care physicians and nurse practitioners as well as several specialties involved. The latter include cardiology, vascular and cardio thoracic surgery, general medicine, radiology, clinical pharmacology and neurology (stroke units).

官方網站

http://benthamscience.com/journal/index.php?journalID=cvp

在線稿件提交

http://benthamscience.com/journal/authors-guidelines.php?journalID=cvp#top

開放訪問

出版商

Bentham Science Publishers B.V.

主題領域

医学

出版國/地區

ENGLAND

發行頻率

四半期刊行

創刊年

2003

每年文章數

36每年文章數趨勢

黃金OA百分比

2.99%

Web of Science 四分位
（ 2023-2024）

WOS Quartile: Q2

Category	Edition	JIF Quartile	JIF Ranking	JIF Percentage
PERIPHERAL VASCULAR DISEASE	SCIE	Q2	31/96
PHARMACOLOGY & PHARMACY	SCIE	Q2	158/354

索引 (SCI or SCIE)

Science Citation Index Expanded

鏈接到PubMed Central (PMC)

https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1570-1611%5BISSN%5D

平均審稿時間 *

來自出版商的數據:
來自作者的數據: Slow, 6-12 Week(s)

競爭力 *

來自作者的數據: Moderate

參考鏈接

相關期刊	【Current Vascular Pharmacology】CiteScore趨勢
自引率趨勢	每年文章數趨勢
作者評論

*所有的審稿過程指標，如接受率和審稿速度，僅限於用戶提交的稿件。因此，這些指標可能無法準確反映期刊的競爭力或速度。

同一學科的期刊
CiteScore趨勢
自引率趨勢
每年文章數趨勢

學科內的可信期刊	影響因子
CIRCULATION	H-index: 570 CiteScore: 45.70
CIRCULATION RESEARCH	H-index: 306 CiteScore: 29.60
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY	H-index: 251 CiteScore: 15.60
HYPERTENSION	H-index: 246 CiteScore: 15.90
International Journal of Stroke	H-index: 59 CiteScore: 13.90
JOURNAL OF THROMBOSIS AND HAEMOSTASIS	H-index: 154 CiteScore: 24.30
THROMBOSIS AND HAEMOSTASIS	H-index: 178 CiteScore: 11.90
ATHEROSCLEROSIS	H-index: 159 CiteScore: 9.80
HYPERTENSION RESEARCH	H-index: 78 CiteScore: 7.40
CURRENT HYPERTENSION REPORTS	H-index: 63 CiteScore: 10.50

學科內最受檢索的期刊	頁面查看次數
CIRCULATION	118406
CIRCULATION RESEARCH	93070
HYPERTENSION	80408
ATHEROSCLEROSIS	77378
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY	66693
JOURNAL OF HYPERTENSION	51813
THROMBOSIS RESEARCH	43913
HYPERTENSION RESEARCH	42858
THROMBOSIS AND HAEMOSTASIS	38868
JOURNAL OF THROMBOSIS AND HAEMOSTASIS	35819

明年預測:
穩步上升無變化逐步下降　刷新

首頁上一頁 1 下一頁末頁 (頁 /1)
[Current Vascular Pharmacology] 的評論	撰寫評論

作者: Burnell ONeil 領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2024-04-10 12:47:16 評論於 It has been three months awaiting editorial approval (0) 讚！ \| Burnell ONeil
作者: 玉女含山領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2022-06-07 22:35:56 評論於 Research focus: Vascular Pharmacology Experience Sharing: Is there any hope without animal experiments? (0) 讚！ \| 玉女含山
作者: 维尔娜菲茨杰拉德領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2021-12-30 19:33:48 評論於 Differences between HIGHLIGHTS and abstract: - Composed of several key words, not necessarily complete sentences. - More concise and shorter in length. - HIGHLIGHTS only include important findings, while abstracts include research purposes and methods (0) 讚！ \| 维尔娜菲茨杰拉德
作者: 维尔娜菲茨杰拉德領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2021-12-30 14:05:54 評論於 The abstract describes the research topic, the source of materials, and the methods and techniques used, allowing readers to understand how the study was conducted. Therefore, the abstract must describe the methods used (0) 讚！ \| 维尔娜菲茨杰拉德
作者: 破戒阳平領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2021-12-27 19:38:37 評論於 What is the difference between abstract and highlights? (0) 讚！ \| 破戒阳平
作者: 魂魄彦露領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2021-12-27 13:41:26 評論於 Does the abstract have to describe the methods used? (0) 讚！ \| 魂魄彦露
作者: Gerald Amelia 領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2020-11-02 21:47:05 評論於 Is it possible for pharmacology without experiments to develop well? (0) 讚！ \| Gerald Amelia
作者: 凌霄高洁領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2017-07-18 14:32:36 評論於 There haven't been any major changes this year, we'll see what happens in the future (0) 讚！ \| 凌霄高洁
作者: 凌霄高洁領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2014-07-30 12:24:36 評論於 It's too stable, can you push a little harder? Isn't it just breaking through 3 points? It's really difficult (0) 讚！ \| 凌霄高洁
作者: 凌霄高洁領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2014-07-29 23:49:43 評論於 Review speed: 2.0 \| Submission success rate: 50.0 Experience sharing: This field is what it is, an old field, no major changes will happen (0) 讚！ \| 凌霄高洁
作者: 凌霄高洁領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2012-11-28 10:26:53 評論於 Can we reach 3 points next year? Let's discuss (0) 讚！ \| 凌霄高洁

首頁上一頁 1 下一頁末頁 (頁 /1)

開始撰寫 [Current Vascular Pharmacology] 的評論：

您的評論將是選擇期刊的重要參考信息。歡迎分享您的投稿經驗！
研究領域:
接受狀態:	審稿時間: 個月以內
您的評論:
姓名:	(建議: 請輸入有效的電子郵件地址以便與審稿者互動，或註冊LetPub帳戶。)
給管理員留言:	我的評論包含修正信息如果您發現該期刊頁面中有錯誤的信息或希望提供額外內容，請勾選此框。管理員將檢查並儘快更新期刊說明。
隨機碼:	點擊刷新

期刊名稱:	ISSN:	主題領域:	影響因子範圍: -
索引:	類別:	開放訪問:	排序方式:

作者: Burnell ONeil 領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2024-04-10 12:47:16 評論於 It has been three months awaiting editorial approval (0) 讚！ \| Burnell ONeil
作者: 玉女含山領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2022-06-07 22:35:56 評論於 Research focus: Vascular Pharmacology Experience Sharing: Is there any hope without animal experiments? (0) 讚！ \| 玉女含山
作者: 维尔娜菲茨杰拉德領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2021-12-30 19:33:48 評論於 Differences between HIGHLIGHTS and abstract: - Composed of several key words, not necessarily complete sentences. - More concise and shorter in length. - HIGHLIGHTS only include important findings, while abstracts include research purposes and methods (0) 讚！ \| 维尔娜菲茨杰拉德
作者: 维尔娜菲茨杰拉德領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2021-12-30 14:05:54 評論於 The abstract describes the research topic, the source of materials, and the methods and techniques used, allowing readers to understand how the study was conducted. Therefore, the abstract must describe the methods used (0) 讚！ \| 维尔娜菲茨杰拉德
作者: 破戒阳平領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2021-12-27 19:38:37 評論於 What is the difference between abstract and highlights? (0) 讚！ \| 破戒阳平
作者: 魂魄彦露領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2021-12-27 13:41:26 評論於 Does the abstract have to describe the methods used? (0) 讚！ \| 魂魄彦露
作者: Gerald Amelia 領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2020-11-02 21:47:05 評論於 Is it possible for pharmacology without experiments to develop well? (0) 讚！ \| Gerald Amelia
作者: 凌霄高洁領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2017-07-18 14:32:36 評論於 There haven't been any major changes this year, we'll see what happens in the future (0) 讚！ \| 凌霄高洁
作者: 凌霄高洁領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2014-07-30 12:24:36 評論於 It's too stable, can you push a little harder? Isn't it just breaking through 3 points? It's really difficult (0) 讚！ \| 凌霄高洁
作者: 凌霄高洁領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2014-07-29 23:49:43 評論於 Review speed: 2.0 \| Submission success rate: 50.0 Experience sharing: This field is what it is, an old field, no major changes will happen (0) 讚！ \| 凌霄高洁
作者: 凌霄高洁領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2012-11-28 10:26:53 評論於 Can we reach 3 points next year? Let's discuss (0) 讚！ \| 凌霄高洁

首頁上一頁 1 下一頁末頁 (頁 /1)

Current Vascular Pharmacology

期刊標題檢索 CURR VASC PHARM 最新評論: It has been three months awaiting editorial approval (2024-04-10)

[Current Vascular Pharmacology]您好，您是該頁面的第 16496 位訪客。

開始撰寫 [Current Vascular Pharmacology] 的評論：

Contact us